Hilhorst, Niels2024-02-162024-02-162023http://hdl.handle.net/20.500.12127/7393The healthcare sector is under immense financial pressure, and many acknowledge that a dramatic shift is required as the current system is not sustainable. Worrisomely, an increase in healthcare spendings does not necessarily seem to equate to better health outcomes or quality of care. Several solutions have been proposed to tackle this issue of which the conceptual framework known as value-based healthcare (VBHC) is further explored in this dissertation for psoriasis. The VBHC framework is formulated on the premise that the healthcare sector should deliver integrated care and strive to maximize the value created – improving quality and performance of care whilst simultaneously using resources in a sustainable and transparent way. Value in this context is defined as the patient-relevant health outcomes achieved divided by the costs needed to achieve these outcomes. Psoriasis is a common chronic inflammatory skin disease that is associated with a high multidimensional disease burden. It is associated with numerous comorbidities and is known to reduce quality of life (QoL) and life expectancy. In recent years major advancements have been made in the treatment of psoriasis and currently a range of treatments is available that can help manage the disease. Despite the substantial burden of psoriasis, nontreatment and undertreatment remain common. Additionally, widespread treatment dissatisfaction exists among persons with psoriasis. The costs associated with managing psoriasis and its comorbidities present a substantial economic burden to the patient and to society. Considering these facts, psoriasis management could benefit from VBHC’s holistic approach. However, the potential of VBHC in dermatology has yet to be fully explored as the concept is relatively new to the field of dermatology and has only been sporadically described in dermatologic literature.enMedicine and Health SciencesPsoriasis275167